Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · IEX Real-Time Price · USD
1.146
+0.036 (3.24%)
Jul 12, 2024, 12:40 PM EDT - Market open

Enzo Biochem Balance Sheet

Millions USD. Fiscal year is Aug - Jul.
Year
20232022202120202019 2018 - 1995
Cash & Equivalents
82.3721.613.5247.8760.15
Upgrade
Short-Term Investments
0029.9800
Upgrade
Cash & Cash Equivalents
82.3721.643.547.8760.15
Upgrade
Cash Growth
281.30%-50.34%-9.12%-20.42%0.17%
Upgrade
Receivables
4.814.7610.29.1410.74
Upgrade
Inventory
7.949.5212.657.787.84
Upgrade
Other Current Assets
3.346.944.233.982.73
Upgrade
Total Current Assets
98.4642.8270.5868.7781.45
Upgrade
Property, Plant & Equipment
16.7116.0233.6134.414.25
Upgrade
Goodwill and Intangibles
007.77.998.48
Upgrade
Other Long-Term Assets
6.7116.771.811.392.45
Upgrade
Total Long-Term Assets
23.4232.7943.1143.7725.19
Upgrade
Total Assets
121.8875.61113.69112.54106.64
Upgrade
Accounts Payable
3.583.728.128.57.26
Upgrade
Current Debt
3.570.93.6511.470.39
Upgrade
Other Current Liabilities
32.858.4114.312.838.36
Upgrade
Total Current Liabilities
39.9913.0226.0832.816.01
Upgrade
Long-Term Debt
3.438.1319.0321.364.6
Upgrade
Total Long-Term Liabilities
3.438.1319.0321.364.6
Upgrade
Total Liabilities
43.4221.1545.1154.1620.61
Upgrade
Total Debt
79.0322.6832.824.99
Upgrade
Debt Growth
-22.47%-60.20%-30.89%557.21%-
Upgrade
Retained Earnings
-268.35-288.64-270.38-278.25-249.73
Upgrade
Comprehensive Income
1.883.151.351.682.58
Upgrade
Shareholders' Equity
78.4654.4668.5958.3886.03
Upgrade
Net Cash / Debt
75.3812.5820.8215.0455.15
Upgrade
Net Cash / Debt Growth
499.31%-39.59%38.40%-72.72%-8.14%
Upgrade
Net Cash Per Share
1.530.260.430.321.16
Upgrade
Working Capital
58.4729.844.5135.9665.44
Upgrade
Book Value Per Share
1.601.121.421.221.82
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).